Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:995-1000
Published online before print September 13, 2007, doi: 10.1161/CIRCRESAHA.107.159228
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
101/10/995    most recent
CIRCRESAHA.107.159228v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, T.
Right arrow Articles by Reidy, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, T.
Right arrow Articles by Reidy, M. A.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2007;101:995.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries

Takuya Shimizu*, Tatsu Nakazawa*, Aesim Cho, Frank Dastvan, Dustin Shilling, Günter Daum, Michael A. Reidy

From the Department of Pathology (T.S., T.N., A.C., F.D., M.A.R.) and Surgery (D.S., G.D.) University of Washington, Seattle.

Correspondence to Michael Reidy, PhD, Department of Pathology, University of Washington, 815 Mercer St, Seattle, WA 98109. E-mail mar1{at}u.washington.edu

Neointimal lesion formation was induced in sphingosine 1-phosphate (S1P) receptor 2 (S1P2)-null and wild-type mice by ligation of the left carotid artery. After 28 days, large neointimal lesions developed in S1P2-null but not in wild-type arteries. This was accompanied with a significant increase in both medial and intimal smooth muscle cell (SMC) replication between days 4 to 28, with only minimal replication in wild-type arteries. S1P2-null SMCs showed a significant increase in migration when stimulated with S1P alone and together with platelet-derived growth factor, whereas both wild-type and null SMCs migrated equally well to platelet-derived growth factor. S1P increased Rho activation in wild-type but not in S1P2-null SMCs, and inhibition of Rho activity promoted S1P-induced SMC migration. Plasma S1P levels were similar and did not change after surgery. These results suggest that activation of S1P2 normally acts to suppress SMC growth in arteries and that S1P is a regulator of neointimal development.


Key Words: sphingosine 1-phosphate receptors • smooth muscle cells • neointima




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. Y. Lee, S. M. Garvey, A. S. Baras, J. A. Lemmon, M. F. Gomez, P. D. Schoppee Bortz, G. Daum, R. C. LeBoeuf, and B. R. Wamhoff
Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells
Hum. Mol. Genet., February 1, 2010; 19(3): 468 - 479.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Daum, A. Grabski, and M.A. Reidy
Sphingosine 1-Phosphate: A Regulator of Arterial Lesions
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. D. Grabski, T. Shimizu, J. Deou, W. M. Mahoney Jr, M. A. Reidy, and G. Daum
Sphingosine-1-Phosphate Receptor-2 Regulates Expression of Smooth Muscle Alpha-Actin After Arterial Injury
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1644 - 1650.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Skoura and T. Hla
Regulation of vascular physiology and pathology by the S1P2 receptor subtype
Cardiovasc Res, May 1, 2009; 82(2): 221 - 228.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S.-i. Takashima, N. Sugimoto, N. Takuwa, Y. Okamoto, K. Yoshioka, M. Takamura, S. Takata, S. Kaneko, and Y. Takuwa
G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase
Cardiovasc Res, September 1, 2008; 79(4): 689 - 697.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. R. Wamhoff, K. R. Lynch, T. L. Macdonald, and G. K. Owens
Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell Phenotype
Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1454 - 1461.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. D. Tang and Y. Anfinogenova
Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 130 - 140.
[Abstract] [PDF]